Olivier Feugeas
Strasbourg, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Beyond Standard Half-Life: Real-world Pharmacokinetics of Efanesoctocog Alfa in a Single Centre.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 17, 2026
Diagnostic Reassessment of a Historical Case of Atypical Heparin-Induced Thrombocytopenia: Between Spontaneous Heparin-Induced Thrombocytopenia and a Vaccine-Induced Immune Thrombotic Thrombocytopenia-Like Syndrome.
Journal: Life (Basel, Switzerland)
Published: October 17, 2025
Long-Term Anticoagulation in a Severe Hemophilia A Patient Receiving Efanesoctocog Alpha Prophylaxis: A Case Report.
Journal: Seminars in thrombosis and hemostasis
Published: September 04, 2025
Turning up the heat: optimizing Bethesda assays for efanesoctocog alfa monitoring.
Journal: Research and practice in thrombosis and haemostasis
Published: July 04, 2025
Placenta percreta management in a patient with a severe congenital hypofibrinogenaemia.
Journal: Annales de biologie clinique
Published: March 14, 2025
Successful Management of Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance After Sotorasib Treatment in a Patient with Non-Small-Cell Lung Carcinoma.
Journal: Hematology reports
Published: February 10, 2025
Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 08, 2024
Placenta percreta management in a patient with a severe congenital hypofibrinogenemia
Journal: Annales de biologie clinique
Published: May 05, 2023
Apixaban for treatment of venous thromboembolism in an obese patient with Glanzmann thrombasthenia.
Journal: Research and practice in thrombosis and haemostasis
Published: April 19, 2023
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia.
Journal: Transfusion medicine (Oxford, England)
Published: January 30, 2022
Use of recombinant Von Willebrand factor during transcatheter aortic valve replacement in a patient with acquired von Willebrand syndrome.
Journal: Transfusion medicine (Oxford, England)
Published: December 15, 2020
Efficacy and safety of a recombinant Von Willebrand Factor treatment in patients with inherited Von Willebrand Disease requiring surgical procedures.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 26, 2020
Last Updated: 09/26/2026